— Agilent Technologies, Inc. (NYSE: A) reported its first-quarter 2020 adjusted earnings of $0.81 per share, up 7% year-over-year. This came in line with the analysts’ expectations.
— Revenue grew by 5.7% to $1.36 billion versus $1.35 billion expected.
— Life Sciences and Applied Markets Group sales rose 5% on continued strength in Environmental & Forensics markets and stable Chemical & Energy.
— Agilent CrossLab Group grew by 6% on continued performance across both services and consumables.
— Diagnostics and Genomics Group saw 6% growth aided by continued strong Nucleic Acids Solutions Division, high single-digit growth in the Next-Generation Sequencing portfolio and mid-single-digit growth in Pathology related businesses.
— Looking ahead into the second quarter of 2020, the company expects revenue in the range of $1.28-1.32 billion and adjusted earnings of $0.72-0.76 per share. Analysts expect EPS of $0.79 on revenue of $1.34 billion.
— The estimated impact of Coronavirus in China of about $10 million revenue deferred into Q2, mostly in Life Sciences and Applied Markets Group.
— For the full year 2020, the company still predicts revenue in the range of $5.50-5.55 billion and adjusted earnings of $3.38-3.43 per share. The consensus estimates EPS of $3.42 on revenue of $5.54 billion.
Most Popular
MU Earnings: Micron Q2 profit jumps on higher revenues, tops expectations
Semiconductor company Micron Technology Inc. (NASDAQ: MU) Thursday reported a sharp increase in revenues and earnings for the second quarter of 2025. Earnings also surpassed Wall Street's forecasts. The Idaho-headquartered
Darden Restaurants sees growth in FY25 and beyond amid menu, tech Innovations
Darden Restaurants, Inc. (NYSE: DRI) has successfully navigated the challenging market environment by constantly innovating its menu offerings and fostering customer loyalty. In the third quarter, sales and profit margin
What to look for when McCormick & Company (MKC) reports Q1 2025 earnings
Shares of McCormick & Company, Incorporated (NYSE: MKC) were down 1% on Thursday. The stock has gained 5% year-to-date. The spice giant is slated to report its first quarter 2025 earnings results
